{"id":447356,"title":"Guidelines for Preparation of New Drug Submissions for Products Used for Estrogen-Progestin Replacement Therapy in Menopause (HRT) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T14:16:17.671000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false","snippet":"Guidelines for Preparation of New Drug Submissions for Products Used for Estrogen-Progestin Replacement Therapy in Menopause (HRT) (PDF Version - 34 K) Contact: BMORS Enquiries Therapeutic Products Programme Tunney's Pasture Address Locator # 0702A Ottawa, Ontario K1A 0L2 April…","rawSnapshotUrl":"/api/snapshots/raw/447356","browseUrl":"https://replay.healtharchive.ca/job-6/20260103141617/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false#ha_snapshot=447356","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}